文献速递儿童感染儿童心血管与肾脏

儿童多系统炎症综合征(MIS-C)的SARS-CoV-2定量血清学特征

Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
PubMed 文献 · Pediatrics · 2020-09-02

该前瞻性研究纳入2020年3月至5月亚特兰大儿童医疗机构的住院儿童,比较MIS-C(n=10)、症状性COVID-19(n=10)、川崎病(n=5)及住院对照(n=4)的SARS-CoV-2抗体水平。发现MIS-C患儿RBD IgG几何平均滴度显著高于其他组,且与中和抗体、炎症指标及住院/ICU时长相关。提示定量血清学可能有助于MIS-C诊断、鉴别及风险分层。

要点

  • MIS-C患儿SARS-CoV-2 RBD IgG滴度显著高于COVID-19、川崎病及住院对照。
  • MIS-C患儿RBD IgG与全长刺突IgG、核衣壳抗体及中和抗体均相关。
  • RBD IgG滴度与红细胞沉降率及住院、ICU时长相关。

核心结论

  • 定量SARS-CoV-2血清学可能有助于MIS-C的诊断、与相似临床实体的鉴别及不良结局风险分层。

研究设计与样本

  • 前瞻性识别2020年3月17日至5月26日亚特兰大儿童医疗机构的住院儿童:MIS-C(n=10)、症状性COVID-19(n=10)、川崎病(n=5)及住院对照(n=4)。
  • 获取前瞻性及残余血样,采用定量酶联免疫吸附试验检测SARS-CoV-2 RBD IgM和IgG、全长刺突IgG及核衣壳蛋白抗体,采用活病毒聚焦减少中和试验检测中和抗体。
  • 对组间对数转换抗体滴度进行统计学比较,并进行线性回归分析。

主要发现

  • 所有MIS-C患儿均有高滴度SARS-CoV-2 RBD IgG抗体,且与全长刺突IgG抗体(R²=0.956;P<.001)、核衣壳蛋白抗体(R²=0.846;P<.001)及中和抗体(R²=0.667;P<.001)相关。
  • 所有MIS-C患儿均可检测到RBD IgM抗体,提示近期SARS-CoV-2感染。
  • RBD IgG滴度与红细胞沉降率(R²=0.512;P<.046)及住院时长(R²=0.548;P=.014)和ICU时长(R²=0.590;P=.010)相关。

临床怎么用

  • 对疑似MIS-C患儿可考虑检测SARS-CoV-2 RBD IgG;高滴度支持MIS-C诊断并有助于与COVID-19、川崎病鉴别。
  • RBD IgG滴度与炎症指标及住院/ICU时长相关,可用于辅助评估病情严重程度及风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to measure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological responses in children hospitalized with multisystem inflammatory syndrome in children (MIS-C) compared with those with coronavirus disease 2019 (COVID-19), those with Kawasaki disease (KD), and hospitalized pediatric controls. METHODS: From March 17, 2020, to May 26, 2020, we prospectively identified hospitalized children with MIS-C (n = 10), symptomatic COVID-19 (n = 10), and KD (n = 5) and hospitalized controls (n = 4) at Children's Healthcare of Atlanta. With institutional review board approval, we obtained prospective and residual blood samples from these children and measured SARS-CoV-2 spike receptor-binding domain (RBD) immunoglobulin M and immunoglobulin G (IgG), full-length spike IgG, and nucleocapsid protein antibodies using quantitative enzyme-linked immunosorbent assays and SARS-CoV-2 neutralizing antibodies using live-virus focus-reduction neutralization assays. We statistically compared the log-transformed antibody titers among groups and performed linear regression analyses. RESULTS: All children with MIS-C had high titers of SARS-CoV-2 RBD IgG antibodies, which correlated with full-length spike IgG antibodies (R 2 = 0.956; P < .001), nucleocapsid protein antibodies (R 2 = 0.846; P < .001), and neutralizing antibodies (R 2 = 0.667; P < .001). Children with MIS-C had significantly higher SARS-CoV-2 RBD IgG antibody titers (geometric mean titer 6800; 95% confidence interval 3495-13 231) than children with COVID-19 (geometric mean titer 626; 95% confidence interval 251-1563; P < .001), children with KD (geometric mean titer 124; 95% confidence interval 91-170; P < .001), and hospitalized controls (geometric mean titer 85; P < .001). All children with MIS-C also had detectable RBD immunoglobulin M antibodies, indicating recent SARS-CoV-2 infection. RBD IgG titers correlated with the erythrocyte sedimentation rate (R 2 = 0.512; P < .046) and with hospital (R 2 = 0.548; P = .014) and ICU lengths of stay (R 2 = 0.590; P = .010). CONCLUSIONS: Quantitative SARS-CoV-2 serology may have a role in establishing the diagnosis of MIS-C, distinguishing it from similar clinical entities, and stratifying risk for adverse outcomes.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Rostad CA, Chahroudi A, Mantus G, et al. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). Pediatrics. 2020. PMID: 32879033. doi:10.1542/peds.2020-018242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。